… perceived as more immunomodulatory than immunosuppressive [22]. … of therapy, concomitant
immunosuppressive therapy, the … and reduction in immunosuppression can cause flares in …

… graft survival, long-term graft attrition rates remained rather constant. Current immunosuppressant
… , ethnicity), on the concomitant immunosuppressive medication, and on the time after …

The advent of potent immunosuppressive drugs to prevent rejection has led to a phenomenal
improvement in renal transplant results increasing spectacularly the number of transplant …

… The monitoring of combined immunosuppression and … the coordinated care of transplant
professionals, pharmacists, … and graft outcomes, the effect of prolonged immunosuppression …

… Of three recent trials of CsA versus Tac with concomitant MPA, two showed … graft failures
and began the analysis with 100% graft survival at 6 months. Our results showed long-term graft …

… of long-term follow-up. Another unresolved issue is the optimum concomitant immunosuppression
… 6 and 12 mo) had the best long-term graft outcome. Hence patients who develop renal …

… of immunosuppression was reduced below the dose found to be associated with good long-term
graft … We did not observe concomitant dose increases for steroids or MMF in patients in …

… of her platelet count and concurrent improvement of other clinical signs of chronic GVHD,
despite discontinuation of all other immunosuppressive agents. Improvement of myasthenia …

… transplant recipients. Sirolimus is a macrocyclic triene antibiotic with immunosuppressive, …
GVHD respectively) where response could not be assessed due to concomitant infection. …

… chronic transplant rejection. According to the results obtained from this study, optimized
immunosuppression … It has also been shown that concomitant administration of sotrastaurin with …